Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6139.34 | 1445 / 1445 | 100% | 115.75 | 183 / 183 |
ovary | 100% | 4603.68 | 180 / 180 | 100% | 65.36 | 430 / 430 |
uterus | 100% | 4569.08 | 170 / 170 | 100% | 118.11 | 459 / 459 |
breast | 100% | 6101.71 | 459 / 459 | 100% | 95.92 | 1117 / 1118 |
lung | 100% | 5162.00 | 577 / 578 | 100% | 96.41 | 1155 / 1155 |
bladder | 100% | 5364.00 | 21 / 21 | 100% | 88.95 | 503 / 504 |
prostate | 100% | 4489.83 | 245 / 245 | 100% | 65.46 | 500 / 502 |
intestine | 100% | 5107.76 | 966 / 966 | 99% | 71.77 | 524 / 527 |
stomach | 100% | 3977.11 | 359 / 359 | 99% | 72.64 | 284 / 286 |
thymus | 100% | 4198.30 | 652 / 653 | 99% | 50.95 | 600 / 605 |
brain | 98% | 2944.60 | 2596 / 2642 | 100% | 47.97 | 705 / 705 |
pancreas | 99% | 2449.01 | 325 / 328 | 99% | 59.54 | 176 / 178 |
liver | 100% | 3364.60 | 226 / 226 | 98% | 38.59 | 396 / 406 |
kidney | 100% | 4455.62 | 89 / 89 | 96% | 42.59 | 863 / 901 |
skin | 100% | 7051.40 | 1809 / 1809 | 96% | 59.18 | 451 / 472 |
adrenal gland | 100% | 6196.94 | 258 / 258 | 83% | 27.98 | 192 / 230 |
adipose | 100% | 6528.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 91.44 | 29 / 29 |
muscle | 100% | 14204.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4059.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 156.04 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.65 | 1 / 1 |
blood vessel | 100% | 4600.95 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 3043.24 | 805 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 3195.23 | 837 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 18.52 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071962 | Biological process | mitotic sister chromatid cohesion, centromeric |
GO_0034087 | Biological process | establishment of mitotic sister chromatid cohesion |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006474 | Biological process | N-terminal protein amino acid acetylation |
GO_0007064 | Biological process | mitotic sister chromatid cohesion |
GO_0005730 | Cellular component | nucleolus |
GO_0031415 | Cellular component | NatA complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0010485 | Molecular function | histone H4 acetyltransferase activity |
GO_0004596 | Molecular function | peptide alpha-N-acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0052858 | Molecular function | peptidyl-lysine acetyltransferase activity |
Gene name | NAA50 |
Protein name | N-alpha-acetyltransferase 50, NatE catalytic subunit N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-epsilon-acetyltransferase 50) (NatE catalytic subunit) N-alpha-acetyltransferase 50 (hNaa50p) (EC 2.3.1.258) (N-acetyltransferase 13) (N-acetyltransferase 5) (hNAT5) (N-acetyltransferase san homolog) (hSAN) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit) |
Synonyms | MAK3 NAT13 NAT5 |
Description | FUNCTION: N-alpha-acetyltransferase that acetylates the N-terminus of proteins that retain their initiating methionine . Has a broad substrate specificity: able to acetylate the initiator methionine of most peptides, except for those with a proline in second position . Also displays N-epsilon-acetyltransferase activity by mediating acetylation of the side chain of specific lysines on proteins . Autoacetylates in vivo . The relevance of N-epsilon-acetyltransferase activity is however unclear: able to acetylate H4 in vitro, but this result has not been confirmed in vivo . Component of N-alpha-acetyltransferase complexes containing NAA10 and NAA15, which has N-alpha-acetyltransferase activity . Does not influence the acetyltransferase activity of NAA10 . However, it negatively regulates the N-alpha-acetyltransferase activity of the N-terminal acetyltransferase A complex (also called the NatA complex) . The multiprotein complexes probably constitute the major contributor for N-terminal acetylation at the ribosome exit tunnel, with NAA10 acetylating all amino termini that are devoid of methionine and NAA50 acetylating other peptides . Required for sister chromatid cohesion during mitosis by promoting binding of CDCA5/sororin to cohesin: may act by counteracting the function of NAA10 . . |
Accessions | ENST00000240922.8 [Q9GZZ1-1] Q9GZZ1 ENST00000497525.5 E7EQ69 B0AZT5 ENST00000630058.1 C9J5D1 ENST00000477813.5 ENST00000493900.5 C9JZU6 ENST00000478020.1 F8WCK0 A0A0D9SF32 C9J5J3 ENST00000493454.5 ENST00000497255.1 ENST00000481432.5 |